NO20064907L - Behandlingsregmie for camptothecin-derivater - Google Patents

Behandlingsregmie for camptothecin-derivater

Info

Publication number: NO20064907L
Authority: NO; Norway
Prior art keywords: treatment regimen; camptothecin derivatives; topoisomerase; inhibitors; treatment
Prior art date: 2004-03-26

Application number

NO20064907A

Other languages

English (en)

Norwegian (no)

Inventor

Horst F Schran

Margaret Ma Woo

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-26

Filing date

2006-10-26

Publication date

2006-12-20

2006-10-26 Application filed by Novartis Ag filed Critical Novartis Ag

2006-12-20 Publication of NO20064907L publication Critical patent/NO20064907L/no

Links

VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title 1
238000011269 treatment regimen Methods 0.000 title 1
229940123780 DNA topoisomerase I inhibitor Drugs 0.000 abstract 1
239000000365 Topoisomerase I Inhibitor Substances 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003534 dna topoisomerase inhibitor Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000002062 proliferating effect Effects 0.000 abstract 1
229940044693 topoisomerase inhibitor Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20064907A 2004-03-26 2006-10-26 Behandlingsregmie for camptothecin-derivater NO20064907L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55672904P	2004-03-26	2004-03-26
PCT/EP2005/003183 WO2005092302A2 (fr)	2004-03-26	2005-03-24	Regime therapeutique pour derives de la camptothecine

Publications (1)

Publication Number	Publication Date
NO20064907L true NO20064907L (no)	2006-12-20

Family

ID=34963082

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064907A NO20064907L (no)	2004-03-26	2006-10-26	Behandlingsregmie for camptothecin-derivater

Country Status (15)

Country	Link
US (1)	US20080262014A1 (fr)
EP (1)	EP1732554A2 (fr)
JP (1)	JP2007530495A (fr)
KR (1)	KR20070010133A (fr)
CN (2)	CN1929842A (fr)
AU (2)	AU2005226932B2 (fr)
BR (1)	BRPI0509240A (fr)
CA (1)	CA2559532A1 (fr)
IL (1)	IL178106A0 (fr)
MA (1)	MA28533B1 (fr)
NO (1)	NO20064907L (fr)
RU (1)	RU2006137657A (fr)
TN (1)	TNSN06305A1 (fr)
WO (1)	WO2005092302A2 (fr)
ZA (1)	ZA200607422B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITRM20050418A1 (it) *	2005-08-04	2007-02-05	Sigma Tau Ind Farmaceuti	Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1044977B1 (fr) *	1999-03-09	2002-05-02	Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.	Dérivés de camptothécine à activité anti-tumorale

2005
- 2005-03-24 BR BRPI0509240-0A patent/BRPI0509240A/pt not_active IP Right Cessation
- 2005-03-24 AU AU2005226932A patent/AU2005226932B2/en not_active Ceased
- 2005-03-24 KR KR1020067019794A patent/KR20070010133A/ko not_active Withdrawn
- 2005-03-24 EP EP05716376A patent/EP1732554A2/fr not_active Withdrawn
- 2005-03-24 JP JP2007504370A patent/JP2007530495A/ja active Pending
- 2005-03-24 CA CA002559532A patent/CA2559532A1/fr not_active Abandoned
- 2005-03-24 WO PCT/EP2005/003183 patent/WO2005092302A2/fr not_active Ceased
- 2005-03-24 CN CNA2005800081703A patent/CN1929842A/zh active Pending
- 2005-03-24 US US10/592,832 patent/US20080262014A1/en not_active Abandoned
- 2005-03-24 RU RU2006137657/15A patent/RU2006137657A/ru not_active Application Discontinuation
- 2005-03-24 CN CNA2008101850224A patent/CN101480395A/zh active Pending
2006
- 2006-09-05 ZA ZA200607422A patent/ZA200607422B/en unknown
- 2006-09-14 IL IL178106A patent/IL178106A0/en unknown
- 2006-09-25 TN TNP2006000305A patent/TNSN06305A1/en unknown
- 2006-10-13 MA MA29387A patent/MA28533B1/fr unknown
- 2006-10-26 NO NO20064907A patent/NO20064907L/no not_active Application Discontinuation
2009
- 2009-06-30 AU AU2009202656A patent/AU2009202656A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2559532A1 (fr)	2005-10-06
AU2009202656A1 (en)	2009-07-23
CN1929842A (zh)	2007-03-14
AU2005226932A1 (en)	2005-10-06
EP1732554A2 (fr)	2006-12-20
AU2005226932B2 (en)	2009-07-09
WO2005092302A3 (fr)	2006-08-03
KR20070010133A (ko)	2007-01-22
JP2007530495A (ja)	2007-11-01
BRPI0509240A (pt)	2007-09-04
CN101480395A (zh)	2009-07-15
IL178106A0 (en)	2006-12-31
TNSN06305A1 (en)	2007-12-03
RU2006137657A (ru)	2008-05-10
MA28533B1 (fr)	2007-04-03
WO2005092302A2 (fr)	2005-10-06
US20080262014A1 (en)	2008-10-23
ZA200607422B (en)	2007-12-27

Similar Documents

Publication	Publication Date	Title
CY1121882T1 (el)	2020-10-14	Αναστολεις πυραζολυλο κινοξαλινο κινασης
EA201000091A1 (ru)	2010-06-30	ПРОИЗВОДНЫЕ МОРФОЛИНОПИРИМИДИНА, ИСПОЛЬЗУЕМЫЕ ПРИ ЗАБОЛЕВАНИЯХ, СВЯЗАННЫХ С mTOR КИНАЗОЙ И/ИЛИ PI3K
JOP20130236B1 (ar)	2021-08-17	تركيبات صيدلانية تشتمل على مثبط b-raf ومثبط egfr ومثبط اختياري لــpi3k alpha
CY1118661T1 (el)	2017-07-12	Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
DOP2010000013A (es)	2010-01-31	Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
DOP2015000100A (es)	2015-12-31	Inhibidores de la tirosina-quinasa de bruton
MA32200B1 (fr)	2011-04-01	Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
BR112015025711A8 (pt)	2019-12-17	uso de ibrutinibe e coposição farmacêutica compreendendo ibrutinibe e um agente anticâncer
SG10201811128RA (en)	2019-01-30	Ezh2 inhibitors for treating lymphoma
DK2324008T3 (da)	2012-07-23	Diarylpyrazol som protein kinase inhibitorer
MX2017014338A (es)	2018-04-11	Seleccion dirigida de pacientes para el tratamiento con derivados de cortistatina.
CO6390066A2 (es)	2012-02-29	Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
EA200970595A1 (ru)	2010-02-26	Производные замещенных индазолов, активные в качестве ингибиторов киназ
UA115131C2 (uk)	2017-09-25	Сполуки боронатного ефіру і його фармацевтичні рецептури
MX2010005631A (es)	2010-06-02	Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
EA201070757A1 (ru)	2011-02-28	Режим дозирования инъекционных препаратов эфиров палиперидона длительного действия
MX2014010590A (es)	2014-09-18	Terapia de combinacion para trastornos proliferativos.
MX2015001122A (es)	2015-04-08	Combinaciones farmaceuticas de un inhibidor de cdk4/6 y un inhibidor de b-raf.
BR112012022243A8 (pt)	2021-11-09	Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
AR096892A1 (es)	2016-02-03	Una combinación farmacéutica para el tratamiento del melanoma
WO2013071056A3 (fr)	2013-07-11	Polythérapie médicamenteuse pour le traitement de tumeurs solides
HK1245153A1 (zh)	2018-08-24	Btk抑制剂组合和给药方案
NO20044498L (no)	2004-11-04	Kombinasjonsterapi for behandling av cancer
EA200901062A1 (ru)	2009-12-30	Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств
NO20064907L (no)	2006-12-20	Behandlingsregmie for camptothecin-derivater

Legal Events

Date	Code	Title	Description
2010-11-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application